CCL Home Page
Up Directory CCL 17.10.02 World Congress on Infectious & Rare Diseases
From: chemistry-request at ccl.net
To: chemistry-request at ccl.net
Date: Wed Mar 15 06:15:54 2017
Subject: 17.10.02 World Congress on Infectious & Rare Diseases
Gavin Conferences invites participants from all over the world to attend “World Congress on Infectious & Rare Diseases” is a three-day conference going to be held at Paris, France from, October 2-4, 2017 and is open to attendees, academics and non-academic audiences.
The three-days conference is designed to bring researchers, scientists, academicians, doctorates, professors, lecturers, scholars and entrepreneurs to discuss research and share ideas regarding career interests to make event experience even better. Infectious diseases are caused by pathogenic microorganisms, such as bacteria, viruses, parasites or fungi. The diseases can be spread, directly or indirectly, from one person to another. During the event, participants can build networks and share information and ideas with one another to make them aware of the infectious diseases its spread, treatment and most probably eradication of the problems caused by it.
NOTE THAT E-MAIL ADDRESSES HAVE BEEN MODIFIED!!!
All @ signs were changed to __ to fight spam. Before you send e-mail, you need to change __ to @
For example: change joe__big123comp.com to joe@big123comp.com
Please let colleagues know about conference listingts at Computational Chemistry List Conference Page at http://www.ccl.net/chemistry/a/conferences/.

Please help: If you find this conference list useful but you noticed some conference missing, please consider including it here by using the Conference Submission Page. It is free but your support is welcome. You will help others!!!

Modified: Wed Mar 15 10:15:54 2017 GMT
Page accessed 3287 times since Wed Mar 15 10:15:55 2017 GMT

Please help maintain CCL: If you found that your conference is listed here, please consider supporting CCL as a Supporting Member or use other Paid Services of CCL to ensure the continuation of this useful service. We cannot do it without your help.